Company Analysis

Medpace Holdings, Inc. (MEDP)

Nasdaq: MEDP · Services-Commercial Physical & Biological Research · Cincinnati, OH · filing with the SEC since 2016
Grade7.8
◀ Past 8.2● Present 7.8▶ Future 7.2

Who runs Medpace Holdings, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Troendle August J.
President & CEO. First filing Aug 2016, latest Oct 1, 2026, 140 filings in all.
Officers reporting now
6
of 12 people with a filing in the last fifteen months
Directors reporting now
6
19 people on the record since 2016
Officerssales are open-market, Nov 2, 2025 to Nov 2, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Ewald Stephen PGeneral Counsel & Corp. Secy.Aug 2016Nov 2, 20262 · $8.2M
Burwig Susan EExec. VP, OperationsAug 2016Oct 28, 20265 · $41.1M
Troendle August J.President & CEOAug 2016Oct 1, 202639 · $359M
Brady Kevin M.CFO & TreasurerAug 2021Aug 24, 20262 · $3.9M
Hansman Brad W.Exec. VP, OperationsJun 2026Jun 4, 2026none
Geiger Jesse JPresidentAug 2016Mar 19, 20262 · $27.2M
Directorssales are open-market, Nov 2, 2025 to Nov 2, 2026
NameRoleFirst filingLatest filingSales, 12 months
Carley Brian TdirectorAug 2016Oct 2, 20261 · $3.0M
Kraft Robert O.directorAug 2016Oct 2, 20262 · $6.2M
Mccarthy Cornelius P. IIIdirectorAug 2018Oct 2, 20262 · $1.2M
Davenport Fred B JrdirectorAug 2018Aug 21, 20261 · $4.4M
Gwadry-Sridhar Femida H.directorJan 2023May 18, 2026none
Zander Dani S.directorJul 2024May 18, 2026none
Earlier names on the record21, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton MEDP · research, not advice